Back to Directory Sharon Appelbaum Nachman Email sharon.nachman@stonybrook.edu Institution SUNY Health Science Center at Stony Brook Title Investigator Request an Update Affiliated Studies IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age DAIDS Number 38932 Research Area Treatment Study Status Pending P1055: Psychiatric Co-Morbidity in Perinatally-Infected Children. DAIDS Number 10049 Research Area Other Study Status Concluded P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child DAIDS Number 10270 Research Area Other Study Status Concluded P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded Show All
IMPAACT 2036: Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age DAIDS Number 38932 Research Area Treatment Study Status Pending
P1055: Psychiatric Co-Morbidity in Perinatally-Infected Children. DAIDS Number 10049 Research Area Other Study Status Concluded
P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded
P1057: Safety & Immunogenicity of Cold Adapted Influenza Vaccine In HIV-Infected Child DAIDS Number 10270 Research Area Other Study Status Concluded
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
